Overview
ADVISORY BUSINESS
A. SV Health Investors, LLC (f/d/b/a SV Life Sciences Advisers, LLC) a Delaware limited
liability company formed on December 15, 2005, is an investment adviser located in
Boston, MA. SV is wholly owned by the Firm’s Members: Michael Ross, Eugene D, Hill,
III, Thomas Flynn, Paul LaViolette, Michael Balmuth, Nikola Trbovic and Greg Madden.
B. As an investment adviser, SV provides investment advisory and sub-advisory
services to pooled investment vehicles (the “Funds”), as well as co-investment and
continuation vehicles formed in connection with the Funds. The Funds are exempt from
registration under the Investment Company Act of 1940, as amended (the “Investment
Company Act”), pursuant to Sections 3(c)(1) and 3(c)(7) of the Investment Company Act.
SV provides discretionary and non-discretionary investment management services to the
Funds pursuant to the Funds’ respective investment management agreements with SV. SV
manages the assets of the Funds in accordance with the limited partnership agreement of
the Funds (“Partnership Agreement”), the Confidential Private Placement Memorandum
of the Funds (“PPM”) and related agreements (together the Partnership Agreement and
PPM, are referred to herein as the “Offering Documents”).
The Firm’s investment objective is to make investments in companies developing and
commercializing important and innovative healthcare products, services and technologies,
across a range of financial instruments. The Firm pursues a multi-strategy investment
approach, and may invest in private companies, public companies, equity, debt and other
structured securities. The Firm generally seeks to make non-control investments.
Information about SV’s advisory services is included in this Brochure and is qualified in
its entirety by information contained in the Offering Documents. Each of the general
partners of the Funds (each and collectively, the “General Partner”) is deemed registered
under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), pursuant to
the registration of SV, in accordance with SEC guidance. The information set forth herein
regarding the investment advisory services provided by SV shall also apply with respect to
the General Partner.
C. SV does not tailor its advisory services to the individual or particular needs of investors in
the Funds. Such investors will accept the terms of advisory services as set forth in the
Offering Documents. The Firm has broad investment authority with respect to the Funds
and, as such, investors should consider whether the investment objectives of the Funds will
be in line with their respective individual objectives and risk tolerance prior to investment.
D. SV does not participate in wrap fee programs.
E. As of the date of December 31, 2023, SV has assets under discretionary management of
approximately $1,146,393,723.